When price cut cards might help reduce the burden of substantial drug fees from the short term, they don't handle the systemic difficulties driving up prescription rates in the U.S. Broader coverage improvements could tackle the foundation leads to of mounting drug price ranges, which include lack of transparency in pricing and the function of inte